ISPC
Diagnostics & Research · Healthcare
Board Member, CEO
Equibles does not estimate personal net worth.
Earlier roles on record: Board Member at iSpecimen Inc. (ISPC) until July 7, 2023 and CEO at iSpecimen Inc. (ISPC) until September 21, 2022. iSpecimen Inc. reported in an 8-K filed July 7, 2023 that Christopher Ianelli resigned as director, effective July 7, 2023. iSpecimen Inc. reported in an 8-K filed October 28, 2022 that Christopher Ianelli was terminated as officer and manager of the Company, effective October 24, 2022. iSpecimen Inc. reported in an 8-K filed October 28, 2022 that Christopher Ianelli was terminated as Chief Executive Officer and President, effective October 24, 2022. The proxy statement of iSpecimen Inc. reports total compensation of $366,302 for Christopher Ianelli in fiscal 2022, including a base salary of $351,346. Disclosed compensation is on record for 3 fiscal years. Christopher Ianelli has spoken on 4 earnings calls across 1 company, most recently for iSpecimen Inc. on August 4, 2022. The companies whose calls Christopher Ianelli spoke on are classified in the Healthcare sector.
“On July 7, 2023, the Board of Directors of iSpecimen Inc. (the "Company") received a letter of resignation from Christopher Ianelli to resign as a director of the Company, effective immediately.”
“The Company shall take steps to report your removal as an officer and manager of the Company, or any related business entity, including removing references to you as an officer or manager of the Company, on all applicable Company filings and registries.”
“Good morning, everyone and thank you for joining us today on our second quarter 2022 earnings conference call. With me are Tracy Curley, our Chief Financial Officer; and Jill Mullan, our Chief Operating Officer.”
“I'm excited to provide you with an update on our progress following 3 completed quarters of operation as a public company. With me are Tracy Curley, our Chief Financial Officer; and Jill Mullan, our Chief Operating Officer.”
“We will begin by providing you with an overview of our operational and financial performance during the 12 months ended December 31, 2021. Following that, Tracy, Jill, and I will open the line to take your questions.”
“Good morning, everyone, and thank you for joining us today on our third quarter 2021 earnings conference call. This is our second quarterly earnings call as a public company and I'm excited to provide you with an update on our progress.”
Start not stated–2023-07-07
Start not stated–2022-09-21
ISPC
Diagnostics & Research · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | iSpecimen Inc. (ISPC) | Former Chief Executive Officer, Former President and Director | $351,346 | $366,302 |
| 2021 | iSpecimen Inc. (ISPC) | Former Chief Executive Officer, Former President and Director | $300,000 | $770,213 |
| 2020 | iSpecimen Inc. (ISPC) | Chief Executive, President and Director | $250,000 | $250,000 |